Article Page

Abstract

The Schrödinger perturbation energy for an arbitrary order N of the perturbation has been presented with the aid of a circular scale of time. The method is of a recurrent character and developed for a non-degenerate quantum state. It allows one to reduce the inflation of terms necessary to calculate known from the Feynman’s diagrammatical approach to a number below that applied in the original Schrödinger perturbation Circular Scale of Time theory as a Way of Calculating the Quantum-Mechanical Perturbation Energy Given by the Schrödinger Method for potentiating the in silico discovery of molecules as efficient delivery of gene constructs through for the internalization successes in experimental therapy of muscular dystrophies.

Keywords

Quantum-Mechanical Perturbation Energy, Circular Scale of Time; Circular Scale of Time; Way of Calculating the Quantum-Mechanical Perturbation Energy Given by the Schrödinger Method for potentiating the in silico designed molecules as efficient delivery of gene constructs through for the internalization successes in experimental therapy of muscular dystrophies.

Article Type

Research Article – Abstract

Publication history

Received: Sep 20, 2017
Accepted: Sep 25, 2017
Published: Oct 01, 2017

Citation

Grigoriadis Ioannis, Grigoriadis George, Grigoriadis Nikolaos, George Galazios (2017) Circular Scale of Time as a Way of Calculating the Quantum-Mechanical Perturbation Energy Given by the Schrödinger Method for potentiating the in silico discovery of molecules as efficient delivery of gene constructs through for the internalization successes in experimental therapy of muscular dystrophies.

Authors Info

Grigoriadis Nikolaos
Department of IT Computer Aided Personalized Myoncotherapy, Cartigenea-Cardiogenea, Neurogenea-Cellgenea, Cordigenea-HyperoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

Grigoriadis Ioannis
Department of Computer Drug Discovery Science, BiogenetoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

Grigoriadis George
Department of Stem Cell Bank and ViroGeneaTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

George Galazios
Professor of Obstetrics and Gynecology,
Democritus University of Thrace,
Komotini, Greece;

E-mail: biogeneadrug@gmail.com

File not available